Ibrahim, Ailen Hazel O.
HRN: 21-66-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2022
CEFUROXIME 1.5GM (VIAL)
08/13/2022
08/14/2022
IV
1.5g
Q8 X3doses
CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes